Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis

Lancet

Volumn 350, Issue 9086, 1997, Pages 1217-1219

  Walter, Dirk H ^a   Schächinger, Volker ^a   Elsner, Mathias ^a   Dimmeler, Stefanie ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR;

ALLELE; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; STENT;

ALLELES; CORONARY DISEASE; CORONARY THROMBOSIS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STENTS;

EID: 0031586491     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)05399-3     Document Type: Article

References (23)

1. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffrè P. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997; 336: 817-22.
2. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993; 22: 135-43.
3. Fischman DL, Leon MB, Baim S, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
4. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
5. Albiero R, Hall P, Itoh A, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Circulation 1997; 95: 1145-56.
6. Baim DS, Carrozza JP. Stent thrombosis. Circulation 1997; 95: 1098-100.
7. Neumann FJ, Gawaz M, Ott I, May A, Mössmer G, Schömig A. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J Am Coll Cardiol 1996; 27: 15-21.
8. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-89.
9. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
10. Karillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. Circulation 1996; 94: 1519-27.
11. Plow EF, Ginsburg MH. Cellular adhesion: GPIIb/IIa as a prototypic adhesion receptor. In: Coller BS, ed. Progress in hemostasis and thrombosis. Philadelphia: Saunders, 1989: 117-56.
12. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
13. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-94.
14. Reiber JHC, Serreuys PW, eds. In: Progress in quantitative coronary arteriography. Dordrecht: Kluwer Academic Publishers, 1994.
15. Schächinger V, Allert M, Kasper W, Just H, Vach W, Zeiher AM. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Circulation 1994; 90: 2258-66.
16. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation 1990; 82: 1193-202.
17. Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 1997; 33: 693-97.
18. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997; 29: 6-12.
19. Schühlen H, Hadamitzky M, Walter H, Ulm K, Schömig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR Trial). Circulation 1997; 95: 2015-21.
20. A polymorphism in young men with myocardial infarction. Lancet 1996; 348: 485-86.
21. A1/A2 polymorphism of platelet glycoprotein IIIa and risk of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-88.
22. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-99.
23. Fernández-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562-69.